Financhill
Back

Harrow 10K Form

Buy
54

HROW
Harrow

Last Price:
13.21
Seasonality Move:
20.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HROW News And Ratings

See the #1 stock for the next 7 days that we like better than HROW

HROW Financial Statistics

Sales & Book Value

Annual Sales: $130.19M
Cash Flow: $8.49M
Price / Cash Flow: 0
Annual Sales: $2.01
Price / Book: 6.6

Profitability

EPS (TTM): -0.76000
Net Income (TTM): $-24.41M
Gross Margin: $90.55M
Return on Equity: -56.34%
Return on Assets: -10.2%

Harrow Earnings Forecast

Key Harrow Financial Ratios

  • The Gross Profit Margin over the past 17 years for HROW is 69.55%.
  • The Selling, General & Administrative Expenses for HROW have been equal to 63.82% of Gross Profit Margin.
  • The Research & Development expenses have been 5.11% of Revenue.
  • The Interest Expense is -87.35% of Operating Income.
  • The Net Earning history of HROW is -18.75% of Total Revenues.
  • Per Share Earnings over the last 18 years have been positive in 9 years.

Harrow Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Current Symbol: HROW
CUSIP: 415858
Website: harrow.com

Debt

Debt-to-Equity Ratio: 2.59
Current Ratio: 2.83
Quick Ratio: 2.42

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 21.31

HROW Technical Analysis vs Fundamental Analysis

Buy
54
Harrow (HROW) is a Buy

Is Harrow a Buy or a Sell?

  • Harrow stock is rated a Buy
    The current Harrow [HROW] share price is $13.21. The Score for HROW is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.